Steel Grove Capital Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$413K Buy
+661
New +$387K 0.04% 151
2025
Q4
– Sell
-665
Closed -$209K – 222
2025
Q3
$209K Hold
665
– – 0.02% 172
2025
Q2
$209K Buy
+665
New +$200K 0.02% 170
2024
Q3
– Sell
-783
Closed -$322K – 185
2024
Q2
$322K Hold
783
– – 0.04% 137
2024
Q1
$316K Hold
783
– – 0.04% 158
2023
Q4
$240K Sell
783
-217
-22% -$58.6K 0.03% 165
2023
Q3
$242K Hold
1,000
– – 0.03% 161
2023
Q2
$240K Buy
+1,000
New +$208K 0.03% 162
2023
Q1
– Sell
-1,000
Closed -$212K – 197
2022
Q4
$212K Buy
+1,000
New +$200K 0.03% 163
2022
Q1
– Sell
-1,000
Closed -$218K – 159
2021
Q4
$218K Buy
+1,000
New +$209K 0.04% 139

Other funds holding MEDP

Steel Grove Capital Advisors's MEDP Position: Q3 2026 in Review

Steel Grove Capital Advisors opened a new position in Medpace (MEDP) in Q3 2026: 661 shares worth $413K. The stake represents 0.04% of the portfolio and ranks #151 among its holdings. This is a return to the name: Steel Grove Capital Advisors previously reported a position in MEDP as recently as Q3 2025.

Steel Grove Capital Advisors first reported a position in MEDP in Q4 2021 and has held it in 10 quarters since. 76 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Steel Grove Capital Advisors held 661 shares of Medpace worth $413K as of Q3 2026.
  • Medpace was a new Steel Grove Capital Advisors position in Q3 2026.
  • Medpace made up 0.04% of Steel Grove Capital Advisors's portfolio in Q3 2026, its #151 holding.
  • Steel Grove Capital Advisors first reported a position in Medpace in Q4 2021 and has held it in 10 quarters since.
  • 76 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Steel Grove Capital Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.